The sector offers compelling investment opportunities for growth-oriented investors. Our analysis ranks these stocks based on fundamental quality, growth metrics, and valuation factors.
Top 3 Picks
1
MAC
The Macerich Company
69.2
Tradestie
Score
Score
Strong fundamentals with consistent execution in the space.
View Analysis
2
LW
Lamb Weston Holdings, Inc.
68.9
Tradestie
Score
Score
Strong fundamentals with consistent execution in the space.
View Analysis
3
PAG
Penske Automotive Group, Inc.
68.8
Tradestie
Score
Score
Strong fundamentals with consistent execution in the space.
View Analysis
Complete Rankings
| Rank | Stock | Score | Trend | Price | Market Cap |
|---|---|---|---|---|---|
|
1
|
The Macerich Company
|
69.2 | Uptrend | $25.83 | $4.55B |
|
2
|
Lamb Weston Holdings, Inc.
|
68.9 | Uptrend | $45.16 | $8.64B |
|
3
|
Penske Automotive Group, Inc.
|
68.8 | Uptrend | $182.21 | $11.67B |
|
4
|
Bank OZK
|
68.8 | Uptrend | $52.11 | $5.71B |
|
5
|
Biogen Inc. Common Stock
|
68.8 | Uptrend | $216.03 | $22.61B |
|
6
|
Elanco Animal Health Incorporated Common Stock
|
68.7 | Uptrend | $24.57 | $10.33B |
|
7
|
Abbott Laboratories
|
68.4 | Uptrend | $94.12 | $232.30B |
|
8
|
Laureate Education, Inc. Common Stock
|
68.3 | Uptrend | $37.12 | $4.61B |
|
9
|
Huntington Bancshares Inc
|
68.3 | Uptrend | $17.79 | $24.86B |
|
10
|
W.W. Grainger, Inc.
|
68.3 | Uptrend | $1353.61 | $45.15B |
|
11
|
GeneDx Holdings Corp. Class A Common Stock
|
68.0 | Uptrend | $69.82 | $3.26B |
|
12
|
Halozyme Therapeutics, Inc.
|
68.0 | Uptrend | $74.96 | $8.77B |
|
13
|
AngioDynamics, Inc.
|
67.8 | Uptrend | $13.40 | $454.71M |
|
14
|
The Allstate Corporation
|
67.5 | Uptrend | $239.61 | $55.52B |
|
15
|
First Trust Indxx Medical Devices ETF
|
67.4 | Uptrend | $19.42 | -- |
|
16
|
Disc Medicine, Inc. Common Stock
|
67.4 | Uptrend | $74.78 | $2.33B |
|
17
|
Citizens Financial Group, Inc.
|
67.4 | Uptrend | $70.40 | $22.75B |
|
18
|
Azenta, Inc.
|
67.3 | Uptrend | $25.50 | $1.45B |
|
19
|
Timberland Bancorp Inc
|
67.2 | Uptrend | $44.80 | $259.98M |
|
20
|
ResMed Inc.
|
67.1 | Uptrend | $200.29 | $39.66B |
|
21
|
Cronos Group Inc. Common Share
|
67.1 | Uptrend | $2.81 | $1.02B |
|
22
|
CEMENTOS PACASMAYO S.A.A.
|
67.0 | Uptrend | $12.03 | $592.50M |
|
23
|
Carrier Global Corporation
|
67.0 | Uptrend | $73.59 | $50.60B |
|
24
|
Blue Bird Corporation Common Stock
|
67.0 | Uptrend | $78.81 | $1.76B |
|
25
|
American Exceptionalism Acquisition Corp. A
|
67.0 | Uptrend | $11.45 | $540.11M |
|
26
|
Starbucks Corp
|
66.9 | Uptrend | $104.60 | $95.94B |
|
27
|
Regeneron Pharmaceuticals Inc
|
66.9 | Uptrend | $632.90 | $63.59B |
|
28
|
Nerdy Inc.
|
66.9 | Uptrend | $0.86 | $150.54M |
|
29
|
BLLN
|
66.9 | Uptrend | $118.17 | -- |
|
30
|
SPDR S&P Retail ETF
|
66.8 | Uptrend | $88.72 | -- |
|
31
|
West Bancorporation
|
66.8 | Uptrend | $26.97 | $341.87M |
|
32
|
SIMA
|
66.8 | Uptrend | $10.89 | -- |
|
33
|
MediaAlpha, Inc.
|
66.8 | Uptrend | $11.88 | $594.05M |
|
34
|
Lake Shore Bancorp, Inc.
|
66.8 | Uptrend | $17.29 | $102.04M |
|
35
|
Kochav Defense Acquisition Corp. Class A Ordinary Shares
|
66.8 | Uptrend | $10.37 | $343.60M |
|
36
|
Incyte Genomics Inc
|
66.8 | Uptrend | $113.75 | $16.93B |
|
37
|
First Trust Small Cap Value AlphaDEX Fund
|
66.8 | Uptrend | $70.06 | -- |
|
38
|
Direxion Daily Gold Miners Index Bear 2X Shares
|
66.8 | Uptrend | $61.16 | -- |
|
39
|
Clean Harbors, Inc
|
66.8 | Uptrend | $301.65 | $12.23B |
|
40
|
BILL Holdings, Inc.
|
66.8 | Uptrend | $35.52 | $5.46B |
|
41
|
BBLB
|
66.8 | Uptrend | $82.56 | -- |
|
42
|
AGMPD
|
66.8 | Uptrend | $20.89 | -- |
|
43
|
ABXB
|
66.8 | Uptrend | $19.65 | -- |
|
44
|
Toll Brothers, Inc.
|
66.7 | Uptrend | $164.14 | $13.49B |
|
45
|
SRGPA
|
66.7 | Uptrend | $21.76 | -- |
|
46
|
3M Company
|
66.7 | Uptrend | $164.01 | $83.09B |
|
47
|
John Marshall Bancorp, Inc. Common Stock
|
66.7 | Uptrend | $22.00 | $277.60M |
|
48
|
Equity Bancshares, Inc.
|
66.7 | Uptrend | $49.61 | $775.26M |
|
49
|
BNDD
|
66.7 | Uptrend | $101.74 | -- |
|
50
|
Inspire Medical Systems, Inc.
|
66.6 | Uptrend | $45.72 | $2.14B |
Methodology
Stocks are ranked using the Tradestie Score, a proprietary 0-100 rating that combines fundamental quality (profitability, balance sheet strength), growth metrics (revenue and earnings growth), valuation (P/E, PEG ratio), and momentum factors. Scores are updated daily based on the latest market data. Learn more about our methodology.